NCT06733220

Brief Summary

Strabismus is a clinical condition characterized by the failure of the visual axes of the two eyes to align on the stared object. There are many possible causes of strabismus, but it can be divided into two main groups: concomitant strabismus, which is characterized by an almost equal angle of deviation in all positions of gaze, and incomitant or paralytic strabismus, which is characterized by a deficit of ocular motility in one or more directions of gaze. Depending on the age of onset, congenital strabismus and acquired strabismus are distinguished. Concomitant strabismus and incomitant strabismus can occur in both plastic age and adults. They are accompanied by diplopia or confusion if they arise in adulthood; there is no diplopia if they arise in plastic age due to cortical compensation mechanisms such as suppression or abnormal retinal matching. Causes of incomitant strabismus in adults can be: decompensation of a preexisting heterophoria; acute incomitant strabismus; injury to fusional centers. Paralytic incomitant strabismus is characterized by a reduction in the force developed by one or more muscles of an eye. Among incomitant strabismus, restrictive strabismus represent clinical pictures of very different etiology united by a single distinguishing feature: the existence of a mechanical obstacle to the free movement of the bulb in the orbit that prevents or reduces the excursion of the eye in one or more directions of gaze. In about 4% of the young population, the sensory and/or motor pathways are not adequately developed, resulting in misalignment of the visual axes and strabismus. Eye surgery for strabismus is one of the most widely used treatment methods. Only a few studies in the literature have analyzed changes in postural control after strabismus surgery and on a limited number of patients. A French study evaluated the effect of surgery on postural control in children with strabismus, concluding that eye surgery affects the somatosensory properties of extraocular muscles, leading to improved postural control and that binocular visual perception could affect the whole body.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Feb 2025Feb 2027

First Submitted

Initial submission to the registry

December 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Expected
Last Updated

March 4, 2025

Status Verified

February 1, 2025

Enrollment Period

11 months

First QC Date

December 10, 2024

Last Update Submit

February 27, 2025

Conditions

Keywords

StrabismusBalanceRisk of fallingQuality of life

Outcome Measures

Primary Outcomes (1)

  • Dynamic balance

    Dynamic balance will be assessed using a robotic platform. Specifically, the reduction in the displacement of the center of pressure under dynamic conditions will be evaluated

    Change from Baseline Dynamic Balance at 30, 90 and 180 days

Secondary Outcomes (13)

  • Cover/Uncover test

    Change from Baseline Cover/Uncover test at 30, 90 and 180 days

  • Cover test with prisms

    Change from Baseline Cover test with prisms at 30, 90 and 180 days

  • Irvine test

    Change from Baseline Irvine test at 30, 90 and 180 days

  • Angle measurement in the various positions of gaze

    Change from Baseline angle measurement at 30, 90 and 180 days

  • Bagolini's Streaked Glasses

    Change from Baseline Bagolini's Streaked Glasses at 30, 90 and 180 days

  • +8 more secondary outcomes

Study Arms (2)

STR-CONG

Patients with congenital strabismus will undergo a comprehensive eye and orthoptic examination and balance test before strabismus surgery at 30 days after surgery, at 90 days after surgery, and at 180 days after surgery.

Procedure: Surgery for strabismus

STR-ACQ

Patients with acquired strabismus will undergo a comprehensive eye and orthoptic examination and balance test before strabismus surgery, at 30 days after surgery, at 90 days after surgery, and at 180 days after surgery.

Procedure: Surgery for strabismus

Interventions

Patients will undergo surgery to correct strabismus, congenital or acquired

STR-ACQSTR-CONG

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with strebismus, congenital or acquired, who will have surgery for surgical correction of strabismus during the study period will be included.

You may qualify if:

  • Age between 16 and 65 years;
  • Presence of congenital strabismus or acquired strabismus in the care of the Ophthalmology OU, the Diagnosis and Treatment of Ocular Motility Disorders OU, and the Pediatric Ophthalmology Outpatient Clinic
  • Ability to maintain balance safely for at least 180 seconds;
  • In case of adult patient, Ability to understand and sign informed consent
  • In case of minor patient, Ability to understand and sign the assent for participation in the study and consent from the parent

You may not qualify if:

  • Presence of diplopia associated with nystagmus;
  • Presence of psychomotor and cognitive delay, as assessed by the Mini Mental State Examination (adjusted score \< 24);
  • Noncooperation of the patient;
  • Inability to provide informed consent, in the case of adult patients.
  • Inability to provide consent in case of minor patients, or consent from parents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, RM, 00168, Italy

RECRUITING

MeSH Terms

Conditions

Strabismus

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Ocular Motility DisordersCranial Nerve DiseasesNervous System DiseasesEye Diseases

Study Officials

  • Annabella Salerni, MD

    Fondazione Policlinico Universitario A. Gemelli, IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 10, 2024

First Posted

December 13, 2024

Study Start

February 5, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

March 4, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations